American Oriental Bioengineering, Inc.
AOBI · OTC
12/31/2012 | 12/31/2011 | 12/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$59,725 | -$68,491 | $16,313 | $41,302 |
| Dep. & Amort. | $12,029 | $12,470 | $12,705 | $12,439 |
| Deferred Tax | $754 | -$5,855 | -$403 | -$978 |
| Stock-Based Comp. | $2,805 | $3,210 | $3,205 | $2,634 |
| Change in WC | -$7,168 | $12,186 | -$24,563 | -$29,186 |
| Other Non-Cash | $4,852 | $76,435 | $776 | -$802 |
| Operating Cash Flow | -$46,453 | $29,956 | $8,033 | $25,409 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$26,143 | -$49,874 | -$6,082 | -$5,099 |
| Net Acquisitions | $18,311 | $5,712 | $0 | $1,119 |
| Inv. Purchases | -$4,665 | -$27,787 | -$54 | -$239 |
| Inv. Sales/Matur. | -$7,479 | $13,478 | $0 | $6,397 |
| Other Inv. Act. | $35,157 | -$13,477 | -$27 | -$1,026 |
| Investing Cash Flow | $15,182 | -$71,949 | -$6,163 | $1,153 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$7,965 | -$3,735 | -$6,631 | -$3,220 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$1,271 | -$800 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$6,250 | $273 | $2,761 | $0 |
| Financing Cash Flow | -$15,486 | -$4,262 | -$3,870 | -$3,220 |
| Forex Effect | $1,227 | $4,314 | $5,442 | $447 |
| Net Chg. in Cash | -$45,531 | -$41,941 | $3,442 | $23,788 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $52,628 | $94,569 | $91,126 | $70,637 |
| End Cash | $7,097 | $52,628 | $94,569 | $94,425 |
| Free Cash Flow | -$72,596 | -$19,918 | $1,952 | $20,310 |